Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Consensus of Chinese experts on hot issues in genetic testing of advanced breast cancer (2021 edition)].

Zhonghua zhong liu za zhi [Chinese journal of oncology] - 23 Jan 2022

Abstract excerpt

Advanced breast cancer is a complicated disease with poor prognosis, which is difficult for salvage treatment. Although advanced breast cancer is difficult to cure at present, we can improve the life quality and prolong survival time of patients by applying optimized treatment. In recent years, with the rapid development of molecular biology and gene testing technology, studies on advanced breast cancer continue...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms
Share to China

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Circulating Tumor DNA

Share to Consensus

Share to Genetic Testing

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Source

Identifiers

PMID: 35073649
DOI: 10.3760/cma.j.cn112152-20211111-00837

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Consensus of Chinese experts on hot issues in genetic testing of advanced breast cancer (2021 edition)].PMID 35073649Read ↗

Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing SuggestionsSemantic proximity Read ↗

What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database.Semantic proximity Read ↗

Genetic Testing Enhances the Precision Diagnosis and Treatment of Breast Cancer.Semantic proximity Read ↗

Germline Variants in 32 Cancer-Related Genes among 700 Chinese Breast Cancer Patients by Next-Generation Sequencing: A Clinic-Based, Observational Study.Semantic proximity Read ↗

Clinical genetics in breast cancer.Semantic proximity Read ↗

Investigation on the clinicopathological characteristics and BRCA1/2 gene variation of patients in breast cancer pedigrees in Northern Henan ProvinceSemantic proximity Read ↗

Real-World Landscape of Genomic Medicine in Breast Cancer Revealed by the C-CAT Database: Reappraisal of Drug Accessibility and Clinical Utility in 6,307 PatientsSemantic proximity Read ↗

Initial assessment of a cancer genomic profile test for patients with metastatic breast cancer: a retrospective studySemantic proximity Read ↗

Clinical Features of Germline Variations in Breast Cancer Patients Revealed by BRCA1 and BRCA2 Genes Using Next Generation SequencingSemantic proximity Read ↗

Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese PopulationSemantic proximity Read ↗

Assessment of a cancer genomic profile test for patients with metastatic breast cancer.Semantic proximity Read ↗

Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.